ReadyCell joined two weeks ago a catalan commercial mission organized by ACCIÓ. During this business trip, ReadyCell representant Francisco Miguel Torres (Sales Manager and Scientific Advisor) visited many Indian top pharmaceutical companies, discussing their potential needs in the ADME-Tox segment and different partering oportunities.

IndiaReadyCell joined two weeks ago a catalan commercial mission organized by ACCIÓ. During this business trip, ReadyCell representant Francisco Miguel Torres (Sales Manager and Scientific Advisor) visited many Indian top pharmaceutical companies, discussing their potential needs in the ADME-Tox segment and different partering oportunities.

ReadyCell also participated in three different B2B events (Delhi, Mumbai and Bangalore), broading its contact network within the indian market and establishing strategic alliances.

Thus, thanks to the support of Government of Catalunya and ACCIO organization effort, ReadyCell effectively increased its visibility in the emerging indian biotechnological and pharmaceutical market.

The effort to increase ReadyCell presence within the indian market is clear. “India is a key player in the drug discovery scenario and therefore, is worthy and necessary to adapt our offer to this extremely competitive market” stated Dr. Torres to Felip Puig, Industry counselor of the Generalitat during their visit to Piramal Life Sciences facilities. (picture)

News from Agencia Catalana de Noticies

El Periodico